Published in Ital J Gastroenterol Hepatol on December 01, 1999
Phospholipase A2 group IIA expression in gastric adenocarcinoma is associated with prolonged survival and less frequent metastasis. Proc Natl Acad Sci U S A (2002) 1.81
Is autoimmunity involved in the relationship between Helicobacter pylori infection, atrophic gastritis and gastric cancer? Ital J Gastroenterol Hepatol (1999) 1.40
Gastritis and hypergastrinemia due to Acinetobacter lwoffii in mice. Infect Immun (2002) 1.02
Non-Helicobacter bacterial flora rarely develops in the gastric mucosal layer of children. Dig Dis Sci (2006) 0.88
The relationship between gastric juice nitrate/nitrite concentrations and gastric mucosal surface pH. Yonsei Med J (2012) 0.81
Kirsten ras mutations in patients with colorectal cancer: the 'RASCAL II' study. Br J Cancer (2001) 5.36
Diagnostic value of an immunoassay to detect anti Campylobacter pylori antibodies in non-ulcer dyspepsia. Lancet (1989) 3.03
[Choice of antibiotics in uncomplicated cystitis; application of 'system of objectified judgement analysis' (SOJA) method]. Ned Tijdschr Geneeskd (1999) 2.97
Search for a resonance decaying into WZ boson pairs in pp collisions. Phys Rev Lett (2010) 2.83
Glutamine and the preservation of gut integrity. Lancet (1993) 2.72
Role of cobalamin intake and atrophic gastritis in mild cobalamin deficiency in older Dutch subjects. Am J Clin Nutr (1998) 2.26
Prognostic significance of radial margins of clearance in rectal cancer. Br J Surg (1996) 2.15
A large non-immunized human Fab fragment phage library that permits rapid isolation and kinetic analysis of high affinity antibodies. J Biol Chem (1999) 2.15
Helicobacter pylori and gastric carcinoma. Histopathology (1990) 1.98
Host specificity of vancomycin-resistant Enterococcus faecium. J Infect Dis (2000) 1.95
Lipoprotein-lipase activity in human skeletal muscle and adipose tissue in the fasting and the fed states. Atherosclerosis (1978) 1.83
Proliferating cell nuclear antigen (PCNA): a new marker to study human colonic cell proliferation. Gut (1994) 1.82
Pancreatic somatostatinoma. Clinical features and physiological implications. Lancet (1977) 1.81
Antibody phage display technology and its applications. Immunotechnology (1998) 1.79
Effect of antibiotic therapy on the antibiotic resistance of faecal Escherichia coli in patients attending general practitioners. J Antimicrob Chemother (1994) 1.77
A multivariate analysis of pathologic prognostic indicators in large bowel cancer. Cancer (1988) 1.72
Serum chromogranin A as a screening test for gastric enterochromaffin-like cell hyperplasia during acid-suppressive therapy. Eur J Clin Invest (2001) 1.69
Interstitial collagen is increased in the non-infarcted human myocardium after myocardial infarction. J Mol Cell Cardiol (1993) 1.66
HLA-DR phenotypes in Spanish coeliac children: their contribution to the understanding of the genetics of the disease. Gut (1983) 1.65
EB/RP gene family encodes tubulin binding proteins. Int J Cancer (1999) 1.63
Parietal cell protrusions and fundic gland cysts during omeprazole maintenance treatment. Hum Pathol (2000) 1.62
Hypergastrinaemia during long-term omeprazole therapy: influences of vagal nerve function, gastric emptying and Helicobacter pylori infection. Aliment Pharmacol Ther (1998) 1.61
Cholecystokinin receptors in human pancreas and gallbladder muscle: a comparative study. Gastroenterology (1996) 1.55
Basaloid squamous cell carcinoma of the maxilla. Oral Oncol (1997) 1.55
Measurement of the forward-backward charge asymmetry in top-quark pair production. Phys Rev Lett (2008) 1.53
An overview of the current diagnosis and recent developments in neuroendocrine tumours of the gastroenteropancreatic tract: the diagnostic approach. Neth J Med (2011) 1.53
Nonulcer dyspepsia in a Dutch working population and Helicobacter pylori. Ulcer history as an explanation of an apparent association. Arch Intern Med (1995) 1.52
Classification of gastric carcinoma using the Goseki system provides prognostic information additional to TNM staging. Cancer (1999) 1.50
Serum gastrin and mucosal somatostatin in Helicobacter pylori-associated gastritis. Scand J Gastroenterol (1995) 1.47
Influence of oropharyngeal flora and specimen pretreatment on the recovery of Helicobacter pylori. Eur J Clin Microbiol Infect Dis (1996) 1.45
Early-life rotavirus and norovirus infections in relation to development of atopic manifestation in infants. Clin Exp Allergy (2008) 1.44
The prevalence of Helicobacter pylori serum antibodies in children with recurrent abdominal pain. Eur J Pediatr (1992) 1.44
Survival of the probiotic, L. plantarum 299v and its effects on the faecal bacterial flora, with and without gastric acid inhibition. Dig Liver Dis (2005) 1.44
Malignant carcinoid tumors. An analysis of 103 patients with regard to tumor localization, hormone production, and survival. Ann Surg (1987) 1.41
Tenascin and fibronectin expression in healing human myocardial scars. J Pathol (1996) 1.40
Omeprazole in peptic ulcers resistant to histamine H2-receptor antagonists. Aliment Pharmacol Ther (1987) 1.38
Predictors for neoplastic progression in patients with Barrett's Esophagus: a prospective cohort study. Am J Gastroenterol (2011) 1.36
Epidemiological aspects of irritable bowel syndrome in Europe and North America. Digestion (2001) 1.35
A profile of differentially expressed genes in primary colorectal cancer using suppression subtractive hybridization. FEBS Lett (1999) 1.30
Efforts to improve interobserver agreement in histopathological grading. J Clin Epidemiol (1995) 1.30
Antibiotic resistance among Escherichia coli isolated from faecal samples of pig farmers and pigs. J Antimicrob Chemother (1996) 1.29
Antibacterial effect of garlic and omeprazole on Helicobacter pylori. J Antimicrob Chemother (1999) 1.29
Medical treatment and long-term survival in a prospective study of 84 patients with endocrine pancreatic tumors. Cancer (1990) 1.28
Type IV collagen immunoreactivity in colorectal cancer. Prognostic value of basement membrane deposition. Cancer (1988) 1.26
Regression analysis of prognostic factors in colorectal cancer after curative resections. Dis Colon Rectum (1988) 1.24
No-touch isolation technique in colon cancer: a controlled prospective trial. Br J Surg (1988) 1.23
Radioimmunoassay of somatostatin. Metabolism (1978) 1.22
MIB-1 labelling index is an independent prognostic marker in primary breast cancer. Br J Cancer (1998) 1.21
Effect of long-term treatment with omeprazole on serum gastrin and serum group A and C pepsinogens in patients with reflux esophagitis. Gastroenterology (1990) 1.19
Distribution of monoclonal antibody-defined monosialoganglioside in normal and cancerous human tissues: an immunoperoxidase study. Hybridoma (1983) 1.18
Interobserver variation in histopathological grading of cervical dysplasia. J Clin Epidemiol (1990) 1.18
Measurements of chromogranin A, chromogranin B (secretogranin I), chromogranin C (secretogranin II) and pancreastatin in plasma and urine from patients with carcinoid tumours and endocrine pancreatic tumours. J Endocrinol (1995) 1.18
Are activity indices helpful in assessing active intestinal inflammation in Crohn's disease? Gut (1989) 1.17
Rapid staining of Campylobacter pyloridis. Histopathology (1987) 1.17
HLA-A and -B antigens in inflammatory bowel disease. Gut (1986) 1.16
Influence of age and Helicobacter pylori infection on serum pepsinogens in healthy blood transfusion donors. Gut (1992) 1.16
The prevalence of anti-Helicobacter (Campylobacter) pylori antibodies in patients and healthy blood donors. J Med Microbiol (1990) 1.14
Antibiotic resistance of Escherichia coli in fecal samples of healthy people in two different areas in an industrialized country. Infection (1992) 1.14
Non-Helicobacter pylori bacterial flora during acid-suppressive therapy: differential findings in gastric juice and gastric mucosa. Aliment Pharmacol Ther (2001) 1.14
The distribution of microsomal glutathione transferase among different organelles, different organs, and different organisms. Biochem Pharmacol (1984) 1.14
Factors influencing noncompliance and contamination in a randomized trial of "Western" (r1) versus "Japanese" (r2) type surgery in gastric cancer. Cancer (1994) 1.13
The parathyroid glands in experimentally induced hypergastrinemia in the rat. Scand J Gastroenterol (1977) 1.12
Gastric morphology and function in dermatitis herpetiformis and in coeliac disease. Scand J Gastroenterol (1985) 1.12
Selection-dominant and nonaccessible epitopes on cell-surface receptors revealed by cell-panning with a large phage antibody library. Eur J Biochem (1999) 1.11
Rage signalling promotes intestinal tumourigenesis. Oncogene (2012) 1.11
The antibiotic susceptibility patterns of uropathogens isolated from general practice patients in southern Netherlands. J Antimicrob Chemother (1994) 1.11
Presence of Helicobacter pylori in patients with non-ulcer dyspepsia revealing normal antral histological characteristics. Digestion (1990) 1.11
Treatment of malignant carcinoid tumors with human leukocyte interferon: long-term results. Cancer Treat Rep (1986) 1.10
Impaired glucose handling in active rheumatoid arthritis: relationship to the secretion of insulin and counter-regulatory hormones. Metabolism (1987) 1.10
Measurement of the electron charge asymmetry in pp[over ]-->W+X-->enu+X events at sqrt[s]=1.96 TeV. Phys Rev Lett (2008) 1.09
Multiple endocrine neoplasia type 1: a 10-year prospective screening study in four kindreds. J Clin Endocrinol Metab (1991) 1.08
Review article: Probiotics in gastrointestinal and liver diseases. Aliment Pharmacol Ther (2007) 1.07
Quality of health care in inflammatory bowel disease: development of a reliable questionnaire (QUOTE-IBD) and first results. Am J Gastroenterol (2001) 1.07
Inflammatory bowel disease versus irritable bowel syndrome: a hospital-based, case-control study of disease impact on quality of life. Scand J Gastroenterol (2003) 1.06
Clearance of inhaled particles from the human nose. Arch Intern Med (1973) 1.06
A detailed analysis of K-ras point mutations in relation to tumor progression and survival in colorectal cancer patients. Int J Cancer (1996) 1.06
Type and number of Ki-ras point mutations relate to stage of human colorectal cancer. Cancer Res (1994) 1.06
Abnormal small bowel permeability and duodenitis in recurrent abdominal pain. Arch Dis Child (1990) 1.05
Participation in colorectal cancer screening trials after first-time invitation: a systematic review. Endoscopy (2011) 1.05
Endocrine cells in colorectal adenocarcinomas: incidence, hormone profile and prognostic relevance. Int J Cancer (1993) 1.05
Mortality and causes of death in Crohn's disease. Review of 50 years' experience in Leiden University Hospital. Gut (1990) 1.04
L-CAM expression in normal, premalignant, and malignant colon mucosa. J Pathol (1992) 1.04
Antral gastrin cells and serum gastrin in achlorhydria. Scand J Gastroenterol (1977) 1.04
Report on a patient with watery diarrhoea syndrome caused by a pancreatic tumour containing neurotensin, enkephalin and calcitonin. Acta Med Scand (1980) 1.04
Search for large extra dimensions via single photon plus missing energy final states at sqrt s = 1.96 TeV. Phys Rev Lett (2008) 1.04
Effect of gluten supplementation in healthy siblings of children with celiac disease. Gastroenterology (1987) 1.03
Retrospective analysis of the prognostic significance of DNA content and proliferative activity in large bowel carcinoma. Cancer Res (1987) 1.03
Relation between IgG and IgA antibody titres against Helicobacter pylori in serum and severity of gastritis in asymptomatic subjects. J Clin Pathol (1994) 1.03